In this episode of The Biomedical Podcast, we explore patient-derived organoids and their impact on precision oncology. Learn how these “tumor-in-a-dish” models, grown from a patient’s own cancer cells, are revolutionizing drug screening, predicting treatment responses, and guiding personalized therapies. We cover organoid culture, success stories, challenges, and how this breakthrough is bridging lab research and tailored cancer care.